Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 88Leukemia, Myeloid, Acute 34Leukemia 32Myelodysplastic Syndromes 22Lymphoma, Follicular 18Lymphoma, Non-Hodgkin 16Lymphoma, B-Cell, Marginal Zone 16Lymphoma 16Lymphoma, Mantle-Cell 15Lymphoma, Large B-Cell, Diffuse 12Waldenstrom Macroglobulinemia 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Myelomonocytic, Chronic 9Burkitt Lymphoma 9Hematologic Neoplasms 8Recurrence 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Plasma Cell 7Lymphoma, Large-Cell, Anaplastic 6Leukemia, B-Cell 6Immunoblastic Lymphadenopathy 6Hodgkin Disease 6Sezary Syndrome 5Mycosis Fungoides 5Leukemia, Hairy Cell 5Intraocular Lymphoma 5Anemia 5

Interventions

Influenza Vaccines 2thymoglobulin 1peginterferon alfa-2a 1fludarabine 1baloxavir 1SARS-CoV-2 inactivated vaccines 1Rituximab 1Oseltamivir 1Melphalan 1Levetiracetam 1Lenalidomide 1Interferons 1Interferon alpha-2 1Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Influenza, Human × Lenalidomide × Other hematologic neoplasm × Clear all
NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
LymphoidOther hematologic neoplasm

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡